BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 31577943)

  • 1. Dissecting the Roles of GABA and Neuropeptides from Rat Central Amygdala CRF Neurons in Anxiety and Fear Learning.
    Pomrenze MB; Giovanetti SM; Maiya R; Gordon AG; Kreeger LJ; Messing RO
    Cell Rep; 2019 Oct; 29(1):13-21.e4. PubMed ID: 31577943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of footshocks on anxiety-like behavior and mRNA levels of precursor peptides for corticotropin releasing factor and opioids in the forebrain of the rat.
    Wang H; Li S; Kirouac GJ
    Neuropeptides; 2015 Dec; 54():1-7. PubMed ID: 26363852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Central Amygdala CRF Circuit Facilitates Learning about Weak Threats.
    Sanford CA; Soden ME; Baird MA; Miller SM; Schulkin J; Palmiter RD; Clark M; Zweifel LS
    Neuron; 2017 Jan; 93(1):164-178. PubMed ID: 28017470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GABA and NMDA receptors in CRF neurons have opposing effects in fear acquisition and anxiety in central amygdala vs. bed nucleus of the stria terminalis.
    Gafford GM; Ressler KJ
    Horm Behav; 2015 Nov; 76():136-42. PubMed ID: 25888455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurotensin and dynorphin Bi-Directionally modulate CeA inhibition of oval BNST neurons in male mice.
    Normandeau CP; Torruella Suárez ML; Sarret P; McElligott ZA; Dumont EC
    Neuropharmacology; 2018 Dec; 143():113-121. PubMed ID: 30248304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Corticotropin Releasing Factor (CRF) Coexpression in GABAergic, Glutamatergic, and GABA/Glutamatergic Subpopulations in the Central Extended Amygdala and Ventral Pallidum of Young Male Primates.
    Fudge JL; Kelly EA; Hackett TA
    J Neurosci; 2022 Nov; 42(48):8997-9010. PubMed ID: 36280261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Central amygdala corticotropin-releasing factor neurons promote hyponeophagia but do not control alcohol drinking in mice.
    Kreifeldt M; Herman MA; Sidhu H; Okhuarobo A; Macedo GC; Shahryari R; Gandhi PJ; Roberto M; Contet C
    Mol Psychiatry; 2022 May; 27(5):2502-2513. PubMed ID: 35264727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optogenetic silencing of a corticotropin-releasing factor pathway from the central amygdala to the bed nucleus of the stria terminalis disrupts sustained fear.
    Asok A; Draper A; Hoffman AF; Schulkin J; Lupica CR; Rosen JB
    Mol Psychiatry; 2018 Apr; 23(4):914-922. PubMed ID: 28439099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Localization of the delta opioid receptor and corticotropin-releasing factor in the amygdalar complex: role in anxiety.
    Reyes BAS; Kravets JL; Connelly KL; Unterwald EM; Van Bockstaele EJ
    Brain Struct Funct; 2017 Mar; 222(2):1007-1026. PubMed ID: 27376372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of CRF and alpha-helical CRF((9-41)) on rat fear responses and amino acids release in the central nucleus of the amygdala.
    Skórzewska A; Bidziński A; Hamed A; Lehner M; Turzyńska D; Sobolewska A; Szyndler J; Maciejak P; Wisłowska-Stanek A; Płaźnik A
    Neuropharmacology; 2009 Aug; 57(2):148-56. PubMed ID: 19477189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell-type specific deletion of GABA(A)α1 in corticotropin-releasing factor-containing neurons enhances anxiety and disrupts fear extinction.
    Gafford GM; Guo JD; Flandreau EI; Hazra R; Rainnie DG; Ressler KJ
    Proc Natl Acad Sci U S A; 2012 Oct; 109(40):16330-5. PubMed ID: 22992651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct populations of corticotropin-releasing factor (CRF) neurons mediate divergent yet complementary defensive behaviors in response to a threat.
    Chudoba R; Dabrowska J
    Neuropharmacology; 2023 May; 228():109461. PubMed ID: 36775096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantified Coexpression Analysis of Central Amygdala Subpopulations.
    McCullough KM; Morrison FG; Hartmann J; Carlezon WA; Ressler KJ
    eNeuro; 2018; 5(1):. PubMed ID: 29445764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein kinase C epsilon mediation of CRF- and ethanol-induced GABA release in central amygdala.
    Bajo M; Cruz MT; Siggins GR; Messing R; Roberto M
    Proc Natl Acad Sci U S A; 2008 Jun; 105(24):8410-5. PubMed ID: 18541912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corticotropin-releasing factor (CRF) and neuropeptide Y (NPY): effects on inhibitory transmission in central amygdala, and anxiety- & alcohol-related behaviors.
    Gilpin NW
    Alcohol; 2012 Jun; 46(4):329-37. PubMed ID: 22560367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amygdalar corticotropin-releasing factor mediates stress-induced anxiety.
    Ventura-Silva AP; Borges S; Sousa N; Rodrigues AJ; Pêgo JM
    Brain Res; 2020 Feb; 1729():146622. PubMed ID: 31881185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Corticotropin Releasing Factor Network in the Extended Amygdala for Anxiety.
    Pomrenze MB; Tovar-Diaz J; Blasio A; Maiya R; Giovanetti SM; Lei K; Morikawa H; Hopf FW; Messing RO
    J Neurosci; 2019 Feb; 39(6):1030-1043. PubMed ID: 30530860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methanol extract of semen Ziziphi Spinosae attenuates ethanol withdrawal anxiety by improving neuropeptide signaling in the central amygdala.
    Li LB; Kim YW; Wang YH; Bai L; Zhu XD; Zhao ZL; Lee CW; Jiao Y; Wu T; Cai ZZ; Kim SC; An WG; Yang CH; Cui GC; Zhao RJ
    BMC Complement Altern Med; 2019 Jun; 19(1):147. PubMed ID: 31234859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sex differences in corticotropin releasing factor peptide regulation of inhibitory control and excitability in central amygdala corticotropin releasing factor receptor 1-neurons.
    Agoglia AE; Tella J; Herman MA
    Neuropharmacology; 2020 Dec; 180():108296. PubMed ID: 32950560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central nucleus of the amygdala projections onto the nucleus accumbens core regulate binge-like alcohol drinking in a CRF-dependent manner.
    Borrego MB; Grigsby KB; Townsley KG; Chan A; Firsick EJ; Tran A; Savarese A; Ozburn AR
    Neuropharmacology; 2022 Feb; 203():108874. PubMed ID: 34748860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.